31. January 2012 00:01
Napp Pharmaceuticals has appointed Dietmar Leitner as its new Managing Director.
Mr Leitner has more than 16 years experience within the pharmaceutical industry having worked at Abbott Laboratories before joining Mundipharma Gesellschaft m.b.H. in Austria.
The new Managing Director says he is “delighted” to be joining the Cambridge-based company and hopes to continue and build on its success.
He succeeds Antony Mattessich who left Napp in May 2011 to become Regional Director Europe at Mundipharma International Limited.
Napp specialises in the field of pain control. It has been committed to furthering the understanding and treatment of pain relief for the last three decades. It also has a growing expertise in oncology and respiratory medicines.
“Napp has significant expertise in analgesics, an expanding oncology portfolio and a very promising respiratory franchise,” commented Mr Leitner. This, alongside our very collaborative approach to business, will, I believe, be a significant strength in the emerging healthcare environment.”